Changed Endocrinology in Postmenopausal Women: A Comprehensive View – Cureus

Specialty

Please choose I'm not a medical professional. Allergy and Immunology Anatomy Anesthesiology Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health Family Medicine Forensic Medicine Gastroenterology General Practice Genetics Geriatrics Health Policy Hematology HIV/AIDS Hospital-based Medicine I'm not a medical professional. Infectious Disease Integrative/Complementary Medicine Internal Medicine Internal Medicine-Pediatrics Medical Education and Simulation Medical Physics Medical Student Nephrology Neurological Surgery Neurology Nuclear Medicine Nutrition Obstetrics and Gynecology Occupational Health Oncology Ophthalmology Optometry Oral Medicine Orthopaedics Osteopathic Medicine Otolaryngology Pain Management Palliative Care Pathology Pediatrics Pediatric Surgery Physical Medicine and Rehabilitation Plastic Surgery Podiatry Preventive Medicine Psychiatry Psychology Pulmonology Radiation Oncology Radiology Rheumatology Substance Use and Addiction Surgery Therapeutics Trauma Urology Miscellaneous

Go here to see the original:

Changed Endocrinology in Postmenopausal Women: A Comprehensive View - Cureus

Cone physician in Rockingham Co. is top national lifestyle doc in fight against diabetes – Greensboro News & Record

REIDSVILLE Local endocrinologist Gebreselassie (Gebre) Nida has recently been recognized as a national leader in treatment of diabetes and promotion of healthy lifestyles.

The prestigious medical report card, the Marquis Whos Who, included Nida in its recent directory of top physicians, according to Cone Health officials.

Nida practices at Cone Healths Reidsville Endocrinology Associates.

While Nida is an accomplished endocrinology and diabetes physician, he is becoming known as an expert in the growing field of lifestyle medicine, according to Cone spokesman Doug Allred.

A marathon runner who practices a health lifestyle himself, Nida is passionate about preventing and reversing Type 2 diabetes and many lifestyle-related chronic diseases, Allred said in a news release.

Lifestyle medicine uses proven methods to make changes in diet, exercise and stress management to improve health. Much of the system centers on removing the root causes of chronic diseases, such as ultra-processed foods and drinks, from the diet.

Nidas vision is to expand this effective and better way of healing, Allred said in the release.

He credits his leaders and team members for the success of the Lifestyle Medicine Steering Committee at Cone Health.

Nida serves as a board member for Annie Penn Hospital Foundation and is the lead physician for the Rockingham County Diabetes Task Force. He leads and contributes to the Greensboro Chapter of Walk with a Doc.

A native of rural Ethiopia, Nida grew up tending animals in rugged conditions.

He raised cattle and sheep in an area without electricity and running water.

And because his father valued education, Nida was allowed to attend an elementary school he reached by walking one hour each way.

By age 12, Nida left home to pursue more specialized education and eventually made it to Addis Ababa University where he earned medical degree in 1999.

Soon after, Nida and his wife, Ethiopia Desta, immigrated to the United States where he pursued postgraduate studies, a residency in internal medicine and a fellowship in endocrinology, diabetes, and metabolism at Wayne State University in Michigan.

Nida joined Cone Health in 2012 where he recently added the new specialty Lifestyle Medicine with a new board certification from American College of Lifestyle Medicine.

An outdoors enthusiast, Nida has competed in 32 marathons, including five Boston Marathon races, and three major world marathons with a personal best time of 2:47:09 at age 48.

Follow this link:

Cone physician in Rockingham Co. is top national lifestyle doc in fight against diabetes - Greensboro News & Record

Deciphering Diabetes Heterogeneity: Advancing Toward Precision Medicine in Diabetes Care – Physician’s Weekly

The following is a summary of Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes, published in the December 2023 issue of Diabetes & Endocrinology by Leslie, et al.

Diabetes is a disorder that shows a great deal of heterogeneity. Yet, it can be diagnosed by detecting a single blood-borne metabolite, glucose, regardless of the underlying cause of the ailment. Disease categorization may become complicated, which might impede progress in research and medical treatment even though it is beneficial from a practical standpoint. For a study, researchers sought to discuss the heterogeneity of diabetes and highlight emerging techniques that might make treatment easier.

The approaches included combining three disease models that apply to all types of diabetes. These models are the gradient model, the threshold model, and the palette model, each individually. Multiple mechanisms that are meant to avoid or bypass metabolic dysfunction are responsible for preventing the further worsening of existing diabetes and the eventual appearance of problems associated with diabetes. Once diabetes has been established, these risks are maintained under control.

The effect of any disease risk factor will differ from person to person based on their history, diabetes-related tendencies, and environmental exposures. This means that the impact of any given disease risk factor will vary. Using precision medicine to define the resultant variability within diabetes, both in terms of the risk of complications and the risk of diabetes itself, can enhance health outcomes in the present and provide light on potential paths for innovative treatment in the future.

Source: sciencedirect.com/science/article/abs/pii/S2213858723001596

View post:

Deciphering Diabetes Heterogeneity: Advancing Toward Precision Medicine in Diabetes Care - Physician's Weekly

Integrating Precision Medicine for Obesity into Type 2 Diabetes Management: A Comprehensive Overview from Past to … – Physician’s Weekly

The following is a summary of Precision medicine of obesity as an integral part of type 2 diabetes management past, present, and future, published in the December 2023 issue of Diabetes & Endocrinology by Szczerbinski, et al.

Several metabolic problems may be ascribed to obesity, which is a condition that is both difficult and varied. One of these metabolic problems is type 2 diabetes. Many people do not achieve lasting weight loss or improvements in metabolic health as a consequence of the fact that the treatment options that are now accessible for obesity are insufficient for some individuals.

It contributed to the fact that many people do not achieve persistent weight loss. The emphasis of this review is on metabolic consequences and the potential implications of these repercussions for personalized therapy of the illness. The study highlighted the developments that have taken place in the field of obesity genetics throughout the last ten years, with a specific focus on major discoveries that have taken place during the preceding five years.

There was also a discussion in this article on the potential role that genetics might have in determining the effectiveness of weight loss programs. Lastly, they provide a vision for the future of precision obesity therapy, which entails the development of an algorithm for the management of several illnesses that are based on obesity and tackles both obesity and the symptoms that accompany it. The algorithm will be used to treat obesity both directly and indirectly. On the other hand, the full realization of its potential and the improvement of metabolic health outcomes would need more research and concerted efforts.

Source: sciencedirect.com/science/article/abs/pii/S2213858723002322

Excerpt from:

Integrating Precision Medicine for Obesity into Type 2 Diabetes Management: A Comprehensive Overview from Past to ... - Physician's Weekly

Genetic clue to pericarditis inflammation points to promising new treatments – News-Medical.Net

Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these cytokines and new a study from deCODE genetics and collaborators can contribute to the further development of this treatment.

A new study called "Variants at the interleukin-1 gene locus and pericarditis" was published today in the journal JAMA Cardiology, by scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Denmark, USA, and Iceland.

The study involves a genome-wide search for variants affecting the risk of pericarditis, a disease characterized by often painful inflammation of the fibrous sack surrounding the heart. A subset of patients experiences recurrent pericarditis that does not respond well to traditional treatment with unspecific anti-inflammatory drugs. The role of specific immune processes in pericarditis is poorly understood and the aim of the study was to use human genetics to shed light on the pathogenesis of the disease.

The scientists found common variants in the genome that protect against pericarditis. They are located in a region with genes encoding interleukin-1 inflammatory cytokines. Drugs inhibiting these cytokines have previously been used to treat other inflammatory diseases and recently they have been tested in clinical studies of recurrent pericarditis with good results. One of these drugs was approved by the US Food and Drug Administration for use in recurrent pericarditis as recently as 2021.

The results of the genetic study provide important insights. They suggest that interleukin-1 may be an important contributor to pericarditis in general, as the identified variants are common (up to approximately 50% frequency). Furthermore, the results provide the foundation for future studies, such as those aimed at understanding which interleukin-1 cytokines are most important and whether response to treatment is affected by genotype.

Source:

Journal reference:

Thorolfsdottir, R. B., et al. (2023). Variants at the Interleukin 1 Gene Locus and Pericarditis. JAMA Cardiology. doi.org/10.1001/jamacardio.2023.4820

See the article here:
Genetic clue to pericarditis inflammation points to promising new treatments - News-Medical.Net

Raha Kapoor’s blue eyes remind fans of her great-grandfather, Raj Kapoor; here’s what genetics says – IndiaTimes

It's already been a day since Raha Kapoor's pap debut, and the internet can not stop gushing over the youngest member of the Kapoor clan. Born on November 6, 2022, to actors Ranbir Kapoor and Alia Bhatt, Raha was always kept away from the limelight by her parents. On Christmas Day, the family of three posed before the media and everyone got the first look of the youngest Kapoor. Raha can also be seen in the Christmas celebration pics of the Kapoors. Fans remember Rishi Kapoor, Ranbir's dad after seeing her. Social media is flooded with pictures comparing Raha with Raj Kapoor, Rishi Kapoor and Shashi Kapoor. But what has caught the attention of all is her eyes. Seems she has acquired the most distinguishable and desired genes of the Kapoor lineage. Yes, blue eyes are an inherited trait, and the color of a person's eyes is determined by the interplay of genetics. Eye color is primarily influenced by the amount and type of pigments in the front part of the iris, the colored part of the eye. Ultimate tips for moms only from Twinkle Khanna The color of the eyes is determined by multiple genes, with the two main types of pigments being melanin (responsible for brown, black, and some shades of green eyes) and lipochrome (responsible for green, blue, and gray eyes). The genetics of eye color inheritance is complex, involving multiple genes with varying degrees of influence. Worried about your teen's group chats? Here's how to reactQuestions every parent must ask in PTM The OCA2 and HERC2 genes, located on chromosome 15, play a significant role in eye color determination. These genes regulate the production and storage of melanin, affecting the amount and distribution of pigments in the iris. Variations in these genes can lead to different eye colors. Blue eyes result from the scattering of light in the iris, rather than the presence of blue pigments. It's the same phenomenon that makes the sky appear blue. The scattering of light occurs when there is little or no melanin in the front part of the iris, allowing light to be scattered rather than absorbed. Motivational quotes for new parents The inheritance of blue eyes follows a recessive pattern. Both parents must carry and pass on the recessive allele for blue eyes to their offspring. If a person inherits one brown-eyed allele and one blue-eyed allele, the brown eye trait is usually dominant, resulting in brown or hazel eyes.

It's important to note that eye color is a polygenic trait influenced by various factors, and predicting the exact eye color of an individual can be challenging. Additionally, environmental factors, such as lighting conditions and the reflection of clothing colors, can create the illusion of different eye colors. In summary, blue eyes are inherited, and the genetic interplay between multiple genes determines eye color. While genetics significantly influence eye color, the precise outcome can vary, contributing to the diversity of eye colors observed in the human population. Raha's striking blue eyes have delighted people around the country and we can only observe if her eyes stay this unique colour or turn darker as she gets older! Only time will tell!

Periods and pregnancy: Why regular cycles are not a guarantee

See the original post:
Raha Kapoor's blue eyes remind fans of her great-grandfather, Raj Kapoor; here's what genetics says - IndiaTimes

Understanding the genetic basis of hereditary diffuse gastric cancer – News-Medical.Net

Gastric cancer, a significant global health burden, claims over 7% of cancer-related deaths annually. Although only 1-3% of cases have a genetic basis, understanding these genetic drivers is crucial for developing preventative strategies.

Gastric cancer, a formidable foe in the global health arena, casts a long shadow over millions of lives each year. While its tendrils reach far and wide, a distinct subset hereditary diffuse gastric cancer (HDGC) emerges as a particularly aggressive and enigmatic adversary. This group of cancers, accounting for roughly 10% of all gastric cancer cases, exhibits a chilling pattern of familial clustering, hinting at a deeper genetic melody playing beneath the surface.

Unraveling the secrets of HDGC has led scientists to a crucial player: the CDH1 gene. This gene, the blueprint for a protein called E-cadherin, acts as the glue that binds cells together, forming the tight-knit communities that make up healthy tissues.

Mutations in CDH1 disrupt this delicate dance, causing cells to lose their grip and embark on a journey of uncontrolled growth the hallmark of cancer. Over 100 unique mutations in CDH1 have been identified, each a discordant note in the symphony of a healthy genome. In roughly 40% of families burdened by HDGC, these mutations act as the conductor, orchestrating the tragic progression of the disease.

However, the story of HDGC is not solely etched in the pages of the CDH1 gene. Other players, like CTNNA1 and MAP3K6, join the chorus, adding layers of complexity to the genetic landscape of this cancer. Like a misplaced instrument, each gene mutation contributes to the disharmony that defines HDGC.

Understanding this intricate interplay of genetic factors remains a key challenge, but it holds immense promise for unlocking new avenues of prevention and treatment.

Despite the lingering mysteries, a beacon of hope shines through prophylactic total gastrectomy (PTG). This surgical procedure, though drastic, offers a life-saving option for individuals with a ticking time bomb of CDH1 mutations and a family history of HDGC. By removing the stomach, the potential breeding ground for cancer, PTG effectively silences the discordant melody and prevents the tragic symphony from playing out. While PTG comes with its own set of challenges, it stands as the only definitive preventive measure currently available for these high-risk individuals.

The battle against HDGC is far from over. Unraveling the complexities of its genetic drivers, deciphering the supporting roles of other genes, and refining our understanding of the interplay between genetics and environment are crucial steps in the fight. With continued research and unwavering dedication, we can hope to one day rewrite the script of HDGC, replacing its tragic verses with a triumphant chorus of prevention and cure.

Source:

Journal reference:

Mokhtari-Esbuie, F., et al. (2023). Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer. eGastroenterology. doi.org/10.1136/egastro-2023-100017.

See the original post:
Understanding the genetic basis of hereditary diffuse gastric cancer - News-Medical.Net

New neuroscience research provides fascinating insights into the mystery of moral cognition – PsyPost

In a new study, neuroscientists have delved deep into the human brains approach to moral judgment. Their findings reveal that our moral decisions activate various, distinct areas of the brain, challenging the notion that morality is processed in a single moral hotspot. The study, published in Nature Human Behaviour, also uncovered intriguing variations in moral perception based on political ideology.

The motivation behind this study lies in one of moral sciences most heated debates: whether our moral reasoning is a monolithic process or a diverse one. At the heart of this debate is the Moral Foundations Theory, which argues for the latter. According to this theory, our moral compass is not guided by a single north star but by multiple, contextually variable moral intuitions.

These foundations include care, fairness, loyalty, authority, sanctity, and more recently identified, liberty. Essentially, this theory suggests that our moral judgments stem from different mental processes, evolved to tackle specific social challenges. The researchers sought to investigate whether our moral judgments about different areas like care, fairness, or loyalty are processed in separate neural systems or whether they converge within a unified framework.

Complex and context-dependent moral judgment is a unique human capacity and at the core of most social interactions among humans, either directly person to person, or mediated. As such, it is an important and fascinating topic to study for a cognitive psychologist, neuroscientist, and communication scientist, said study author Ren Weber, a professor at the University of California Santa Barbara and director of UCSBs Media Neuroscience Lab.

To explore this, the researchers conducted an experiment involving 64 participants, mainly young adults from the University of California, Santa Barbara community. Participants underwent a functional Magnetic Resonance Imaging (fMRI) scan, a technology that visualizes brain activity by detecting changes associated with blood flow.

During the scans, participants engaged in a task involving Moral Foundations Vignettes short descriptions of actions violating specific moral foundations. The vignettes also included non-moral social norm transgressions, such as eating cereal with water instead of milk, which served as a control. Participants rated these actions based on their perceived moral wrongness. This setup allowed the researchers to observe which parts of the brain were activated during different moral judgments.

As expected, the moral violations (physical care, emotional care, fairness, liberty, authority, loyalty, and sanctity) were judged as more morally wrong than social norm transgressions. Judging moral transgressions also took longer on average than judging social norm transgressions, suggesting a deeper cognitive process involved in evaluating moral actions.

The researchers found that different brain areas were activated for moral violations compared to social norm transgressions. A distributed network involving areas like the dorsomedial prefrontal cortex, posterior cingulate cortex, temporoparietal junction, and primary visual cortex showed common activation across all moral foundations. This suggests that these areas of the brain are pivotal in discerning moral judgments from non-moral social norm transgressions.

When examining how specific moral foundations were processed in the brain, the researchers discovered that each of these moral categories elicited unique patterns of brain activity. This finding is particularly significant as it aligns with the Moral Foundations Theory, which posits that different moral considerations are rooted in separate cognitive processes.

A significant achievement of the study was the development of a decoding model capable of predicting which specific moral foundation or social norm an individual was judging, based on the activity patterns across their brain. This level of prediction would not be feasible if all moral categories were processed uniformly at the neurological level.

Our findings indicated that there are very specific neural signatures of different moral dimensions or foundations, Weber told PsyPost. These signatures can even be used to decode moral judgment, that is, to predict individuals moral judgement from their brain activation pattern. The accuracy with which this can be done was surprising to us. We are currently testing moral decoding across different datasets and problems and try to replicate our findings in our Nature Human Behavior article.

The researchers also found that liberals and conservatives exhibited distinct patterns of brain activation when making moral judgments. This suggests that an individuals political orientation is not just a reflection of their social and moral beliefs, but it also influences the fundamental neural processes underlying these beliefs.

Liberals showed more pronounced neural responses to moral transgressions related to care/harm and fairness/cheating. These foundations typically protect the rights and freedoms of individuals. The heightened sensitivity of liberals to these moral dimensions was reflected in the specific activation patterns in their brains.

On the other hand, conservatives displayed greater neural engagement when processing moral issues related to loyalty/betrayal, authority/subversion, and sanctity/degradation. These categories generally operate at the group level, emphasizing group cohesion, respect for authority, and purity. The brain scans of conservatives showed that they are neurologically more attuned to these aspects of moral reasoning.

For example, in judging individualizing versus binding moral foundations, the lingual gyrus, visual cortex, anterior prefrontal cortex, and superior temporal cortex showed significant differences in activity between liberals and conservatives. These areas are associated with various cognitive functions, including semantic processing and intention attribution, suggesting that ideological differences might affect fundamental cognitive processing during moral judgments.

Together, the findings challenge the idea of a singular moral hotspot in the brain. Instead, it suggests that our moral judgments are the result of a more distributed neural process.

Morality or moral judgment is not just one thing or arises from just one concern (e.g. from harming or caring for other individuals), Weber told PsyPost. At its core, moralitys function is to facilitate (group) cohesion and cooperation among humans. Because there are many cooperative problems to solve, moral judgement is diverse, and different individuals develop different moral sensibilities.

In many ways, I think our findings clarify that monism and pluralism are not necessarily mutually exclusive approaches, added first author Frederic Hopp, who led the study as a doctoral student in the Media Neuroscience Lab. We show that moral judgments of a wide range of different types of morally relevant behaviors are instantiated in shared brain regions.

Despite these significant findings, the study has its limitations. For one, the sample size and demographic (mostly young, university-affiliated adults) might not represent the full spectrum of moral cognition across different ages, cultures, and backgrounds. Also, while fMRI is a powerful tool, it has its constraints in pinpointing the exact neural mechanisms at play.

Future research might focus on broadening the demographic diversity of participants or employing even more advanced neuroimaging techniques. Furthermore, exploring how moral decision-making develops over time and in different cultural contexts could add another layer of understanding to this complex facet of human cognition.

There are dozens of additional questions to be addressed, Weber said. The question of why and how moral judgment works has been an important topic for scholars from diverse backgrounds for millennia, and it will keep scholars busy for a long time. For us, our next goals are testing different theories of moral judgment against each other and to replicate our findings in our Nature Human Behavior article in more diverse populations.

The study, Moral foundations elicit shared and dissociable cortical activation modulated by political ideology, was authored by Frederic R. Hopp, Ori Amir, Jacob T. Fisher, Scott Grafton, Walter Sinnott-Armstrong, and Ren Weber.

The rest is here:
New neuroscience research provides fascinating insights into the mystery of moral cognition - PsyPost